Global Pulmonary Drugs Sales Market Report 2017

October 2017 | 105 pages | ID: GCA2C989657PEN
QYResearch

Abstracts

In this report, the global Pulmonary Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Pulmonary Drugs for these regions, from 2012 to 2022 (forecast), covering

• United States
• China
• Europe
• Japan
• Southeast Asia
• India

Global Pulmonary Drugs market competition by top manufacturers/players, with Pulmonary Drugs sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• AstraZeneca plc
• Bayer AG'
• Teva Pharmaceutical Industries Ltd.'
• Actelion Pharmaceuticals, Inc.
• Boehringer Ingelheim GmbH
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Novartis AG
• GlaxoSmithKline plc
• Sunovion Pharmaceuticals, Inc.'

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Inhaled Corticosteroids (ICS)
• Long-Acting Beta2-Agonists (LABA)
• Antihistamine
• Vasodilators
• Short-Acting Beta2-Agonists (SABA)
• Anticholinergics
• Combination Drugs
• MAbs
• Enzymes
• Antibiotics & Antileukotrienes

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Pulmonary Drugs for each application, including

• Asthma & COPD
• Allergic Rhinitis
• Pulmonary Arterial Hypertension
• Cystic Fibrosis

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Global Pulmonary Drugs Sales Market Report 2017

1 PULMONARY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Pulmonary Drugs
1.2 Classification of Pulmonary Drugs by Product Category
  1.2.1 Global Pulmonary Drugs Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 Global Pulmonary Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Inhaled Corticosteroids (ICS)
  1.2.4 Long-Acting Beta2-Agonists (LABA)
  1.2.5 Antihistamine
  1.2.6 Vasodilators
  1.2.7 Short-Acting Beta2-Agonists (SABA)
  1.2.8 Anticholinergics
  1.2.9 Combination Drugs
  1.2.10 MAbs
  1.2.11 Enzymes
  1.2.12 Antibiotics & Antileukotrienes
1.3 Global Pulmonary Drugs Market by Application/End Users
  1.3.1 Global Pulmonary Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022)
  1.3.2 Asthma & COPD
  1.3.3 Allergic Rhinitis
  1.3.4 Pulmonary Arterial Hypertension
  1.3.5 Cystic Fibrosis
1.4 Global Pulmonary Drugs Market by Region
  1.4.1 Global Pulmonary Drugs Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 United States Pulmonary Drugs Status and Prospect (2012-2022)
  1.4.3 China Pulmonary Drugs Status and Prospect (2012-2022)
  1.4.4 Europe Pulmonary Drugs Status and Prospect (2012-2022)
  1.4.5 Japan Pulmonary Drugs Status and Prospect (2012-2022)
  1.4.6 Southeast Asia Pulmonary Drugs Status and Prospect (2012-2022)
  1.4.7 India Pulmonary Drugs Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Pulmonary Drugs (2012-2022)
  1.5.1 Global Pulmonary Drugs Sales and Growth Rate (2012-2022)
  1.5.2 Global Pulmonary Drugs Revenue and Growth Rate (2012-2022)

2 GLOBAL PULMONARY DRUGS COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Pulmonary Drugs Market Competition by Players/Suppliers
  2.1.1 Global Pulmonary Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Global Pulmonary Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Pulmonary Drugs (Volume and Value) by Type
  2.2.1 Global Pulmonary Drugs Sales and Market Share by Type (2012-2017)
  2.2.2 Global Pulmonary Drugs Revenue and Market Share by Type (2012-2017)
2.3 Global Pulmonary Drugs (Volume and Value) by Region
  2.3.1 Global Pulmonary Drugs Sales and Market Share by Region (2012-2017)
  2.3.2 Global Pulmonary Drugs Revenue and Market Share by Region (2012-2017)
2.4 Global Pulmonary Drugs (Volume) by Application

3 UNITED STATES PULMONARY DRUGS (VOLUME, VALUE AND SALES PRICE)

3.1 United States Pulmonary Drugs Sales and Value (2012-2017)
  3.1.1 United States Pulmonary Drugs Sales and Growth Rate (2012-2017)
  3.1.2 United States Pulmonary Drugs Revenue and Growth Rate (2012-2017)
  3.1.3 United States Pulmonary Drugs Sales Price Trend (2012-2017)
3.2 United States Pulmonary Drugs Sales Volume and Market Share by Players
3.3 United States Pulmonary Drugs Sales Volume and Market Share by Type
3.4 United States Pulmonary Drugs Sales Volume and Market Share by Application

4 CHINA PULMONARY DRUGS (VOLUME, VALUE AND SALES PRICE)

4.1 China Pulmonary Drugs Sales and Value (2012-2017)
  4.1.1 China Pulmonary Drugs Sales and Growth Rate (2012-2017)
  4.1.2 China Pulmonary Drugs Revenue and Growth Rate (2012-2017)
  4.1.3 China Pulmonary Drugs Sales Price Trend (2012-2017)
4.2 China Pulmonary Drugs Sales Volume and Market Share by Players
4.3 China Pulmonary Drugs Sales Volume and Market Share by Type
4.4 China Pulmonary Drugs Sales Volume and Market Share by Application

5 EUROPE PULMONARY DRUGS (VOLUME, VALUE AND SALES PRICE)

5.1 Europe Pulmonary Drugs Sales and Value (2012-2017)
  5.1.1 Europe Pulmonary Drugs Sales and Growth Rate (2012-2017)
  5.1.2 Europe Pulmonary Drugs Revenue and Growth Rate (2012-2017)
  5.1.3 Europe Pulmonary Drugs Sales Price Trend (2012-2017)
5.2 Europe Pulmonary Drugs Sales Volume and Market Share by Players
5.3 Europe Pulmonary Drugs Sales Volume and Market Share by Type
5.4 Europe Pulmonary Drugs Sales Volume and Market Share by Application

6 JAPAN PULMONARY DRUGS (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Pulmonary Drugs Sales and Value (2012-2017)
  6.1.1 Japan Pulmonary Drugs Sales and Growth Rate (2012-2017)
  6.1.2 Japan Pulmonary Drugs Revenue and Growth Rate (2012-2017)
  6.1.3 Japan Pulmonary Drugs Sales Price Trend (2012-2017)
6.2 Japan Pulmonary Drugs Sales Volume and Market Share by Players
6.3 Japan Pulmonary Drugs Sales Volume and Market Share by Type
6.4 Japan Pulmonary Drugs Sales Volume and Market Share by Application

7 SOUTHEAST ASIA PULMONARY DRUGS (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Pulmonary Drugs Sales and Value (2012-2017)
  7.1.1 Southeast Asia Pulmonary Drugs Sales and Growth Rate (2012-2017)
  7.1.2 Southeast Asia Pulmonary Drugs Revenue and Growth Rate (2012-2017)
  7.1.3 Southeast Asia Pulmonary Drugs Sales Price Trend (2012-2017)
7.2 Southeast Asia Pulmonary Drugs Sales Volume and Market Share by Players
7.3 Southeast Asia Pulmonary Drugs Sales Volume and Market Share by Type
7.4 Southeast Asia Pulmonary Drugs Sales Volume and Market Share by Application

8 INDIA PULMONARY DRUGS (VOLUME, VALUE AND SALES PRICE)

8.1 India Pulmonary Drugs Sales and Value (2012-2017)
  8.1.1 India Pulmonary Drugs Sales and Growth Rate (2012-2017)
  8.1.2 India Pulmonary Drugs Revenue and Growth Rate (2012-2017)
  8.1.3 India Pulmonary Drugs Sales Price Trend (2012-2017)
8.2 India Pulmonary Drugs Sales Volume and Market Share by Players
8.3 India Pulmonary Drugs Sales Volume and Market Share by Type
8.4 India Pulmonary Drugs Sales Volume and Market Share by Application

9 GLOBAL PULMONARY DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 AstraZeneca plc
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Pulmonary Drugs Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 AstraZeneca plc Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.1.4 Main Business/Business Overview
9.2 Bayer AG?
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Pulmonary Drugs Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Bayer AG? Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.2.4 Main Business/Business Overview
9.3 Teva Pharmaceutical Industries Ltd.?
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Pulmonary Drugs Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Teva Pharmaceutical Industries Ltd.? Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.3.4 Main Business/Business Overview
9.4 Actelion Pharmaceuticals, Inc.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Pulmonary Drugs Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Actelion Pharmaceuticals, Inc. Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.4.4 Main Business/Business Overview
9.5 Boehringer Ingelheim GmbH
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Pulmonary Drugs Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 Boehringer Ingelheim GmbH Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.5.4 Main Business/Business Overview
9.6 F. Hoffmann-La Roche Ltd.
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Pulmonary Drugs Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 F. Hoffmann-La Roche Ltd. Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.6.4 Main Business/Business Overview
9.7 Merck & Co., Inc.
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Pulmonary Drugs Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Merck & Co., Inc. Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.7.4 Main Business/Business Overview
9.8 Novartis AG
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Pulmonary Drugs Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Novartis AG Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.8.4 Main Business/Business Overview
9.9 GlaxoSmithKline plc
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Pulmonary Drugs Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 GlaxoSmithKline plc Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.9.4 Main Business/Business Overview
9.10 Sunovion Pharmaceuticals, Inc.?
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Pulmonary Drugs Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Sunovion Pharmaceuticals, Inc.? Pulmonary Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
  9.10.4 Main Business/Business Overview

10 PULMONARY DRUGS MAUFACTURING COST ANALYSIS

10.1 Pulmonary Drugs Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Pulmonary Drugs
10.3 Manufacturing Process Analysis of Pulmonary Drugs

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Pulmonary Drugs Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Pulmonary Drugs Major Manufacturers in 2016
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL PULMONARY DRUGS MARKET FORECAST (2017-2022)

14.1 Global Pulmonary Drugs Sales Volume, Revenue and Price Forecast (2017-2022)
  14.1.1 Global Pulmonary Drugs Sales Volume and Growth Rate Forecast (2017-2022)
  14.1.2 Global Pulmonary Drugs Revenue and Growth Rate Forecast (2017-2022)
  14.1.3 Global Pulmonary Drugs Price and Trend Forecast (2017-2022)
14.2 Global Pulmonary Drugs Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  14.2.1 Global Pulmonary Drugs Sales Volume and Growth Rate Forecast by Regions (2017-2022)
  14.2.2 Global Pulmonary Drugs Revenue and Growth Rate Forecast by Regions (2017-2022)
  14.2.3 United States Pulmonary Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.4 China Pulmonary Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.5 Europe Pulmonary Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.6 Japan Pulmonary Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.7 Southeast Asia Pulmonary Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
  14.2.8 India Pulmonary Drugs Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Pulmonary Drugs Sales Volume, Revenue and Price Forecast by Type (2017-2022)
  14.3.1 Global Pulmonary Drugs Sales Forecast by Type (2017-2022)
  14.3.2 Global Pulmonary Drugs Revenue Forecast by Type (2017-2022)
  14.3.3 Global Pulmonary Drugs Price Forecast by Type (2017-2022)
14.4 Global Pulmonary Drugs Sales Volume Forecast by Application (2017-2022)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pulmonary Drugs
Figure Global Pulmonary Drugs Sales Volume Comparison (K Units) by Type (2012-2022)
Figure Global Pulmonary Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Inhaled Corticosteroids (ICS) Product Picture
Figure Long-Acting Beta2-Agonists (LABA) Product Picture
Figure Antihistamine Product Picture
Figure Vasodilators Product Picture
Figure Short-Acting Beta2-Agonists (SABA) Product Picture
Figure Anticholinergics Product Picture
Figure Combination Drugs Product Picture
Figure MAbs Product Picture
Figure Enzymes Product Picture
Figure Antibiotics & Antileukotrienes Product Picture
Figure Global Pulmonary Drugs Sales Comparison (K Units) by Application (2012-2022)
Figure Global Sales Market Share of Pulmonary Drugs by Application in 2016
Figure Asthma & COPD Examples
Figure Allergic Rhinitis Examples
Figure Pulmonary Arterial Hypertension Examples
Figure Cystic Fibrosis Examples
Figure Global Pulmonary Drugs Market Size (Million USD) by Regions (2012-2022)
Figure United States Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Pulmonary Drugs Sales Volume (K Units) and Growth Rate (2012-2022)
Figure Global Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Pulmonary Drugs Sales Volume (K Units) (2012-2017)
Table Global Pulmonary Drugs Sales (K Units) of Key Players/Suppliers (2012-2017)
Table Global Pulmonary Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Pulmonary Drugs Sales Share by Players/Suppliers
Figure 2017 Pulmonary Drugs Sales Share by Players/Suppliers
Figure Global Pulmonary Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Pulmonary Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Pulmonary Drugs Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Pulmonary Drugs Revenue Share by Players
Table 2017 Global Pulmonary Drugs Revenue Share by Players
Table Global Pulmonary Drugs Sales (K Units) and Market Share by Type (2012-2017)
Table Global Pulmonary Drugs Sales Share (K Units) by Type (2012-2017)
Figure Sales Market Share of Pulmonary Drugs by Type (2012-2017)
Figure Global Pulmonary Drugs Sales Growth Rate by Type (2012-2017)
Table Global Pulmonary Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Pulmonary Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pulmonary Drugs by Type (2012-2017)
Figure Global Pulmonary Drugs Revenue Growth Rate by Type (2012-2017)
Table Global Pulmonary Drugs Sales Volume (K Units) and Market Share by Region (2012-2017)
Table Global Pulmonary Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Pulmonary Drugs by Region (2012-2017)
Figure Global Pulmonary Drugs Sales Growth Rate by Region in 2016
Table Global Pulmonary Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Pulmonary Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Pulmonary Drugs by Region (2012-2017)
Figure Global Pulmonary Drugs Revenue Growth Rate by Region in 2016
Table Global Pulmonary Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Pulmonary Drugs Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Pulmonary Drugs by Region (2012-2017)
Figure Global Pulmonary Drugs Revenue Market Share by Region in 2016
Table Global Pulmonary Drugs Sales Volume (K Units) and Market Share by Application (2012-2017)
Table Global Pulmonary Drugs Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Pulmonary Drugs by Application (2012-2017)
Figure Global Pulmonary Drugs Sales Market Share by Application (2012-2017)
Figure United States Pulmonary Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure United States Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Pulmonary Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table United States Pulmonary Drugs Sales Volume (K Units) by Players (2012-2017)
Table United States Pulmonary Drugs Sales Volume Market Share by Players (2012-2017)
Figure United States Pulmonary Drugs Sales Volume Market Share by Players in 2016
Table United States Pulmonary Drugs Sales Volume (K Units) by Type (2012-2017)
Table United States Pulmonary Drugs Sales Volume Market Share by Type (2012-2017)
Figure United States Pulmonary Drugs Sales Volume Market Share by Type in 2016
Table United States Pulmonary Drugs Sales Volume (K Units) by Application (2012-2017)
Table United States Pulmonary Drugs Sales Volume Market Share by Application (2012-2017)
Figure United States Pulmonary Drugs Sales Volume Market Share by Application in 2016
Figure China Pulmonary Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure China Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Pulmonary Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table China Pulmonary Drugs Sales Volume (K Units) by Players (2012-2017)
Table China Pulmonary Drugs Sales Volume Market Share by Players (2012-2017)
Figure China Pulmonary Drugs Sales Volume Market Share by Players in 2016
Table China Pulmonary Drugs Sales Volume (K Units) by Type (2012-2017)
Table China Pulmonary Drugs Sales Volume Market Share by Type (2012-2017)
Figure China Pulmonary Drugs Sales Volume Market Share by Type in 2016
Table China Pulmonary Drugs Sales Volume (K Units) by Application (2012-2017)
Table China Pulmonary Drugs Sales Volume Market Share by Application (2012-2017)
Figure China Pulmonary Drugs Sales Volume Market Share by Application in 2016
Figure Europe Pulmonary Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Pulmonary Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Europe Pulmonary Drugs Sales Volume (K Units) by Players (2012-2017)
Table Europe Pulmonary Drugs Sales Volume Market Share by Players (2012-2017)
Figure Europe Pulmonary Drugs Sales Volume Market Share by Players in 2016
Table Europe Pulmonary Drugs Sales Volume (K Units) by Type (2012-2017)
Table Europe Pulmonary Drugs Sales Volume Market Share by Type (2012-2017)
Figure Europe Pulmonary Drugs Sales Volume Market Share by Type in 2016
Table Europe Pulmonary Drugs Sales Volume (K Units) by Application (2012-2017)
Table Europe Pulmonary Drugs Sales Volume Market Share by Application (2012-2017)
Figure Europe Pulmonary Drugs Sales Volume Market Share by Application in 2016
Figure Japan Pulmonary Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Japan Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Pulmonary Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Japan Pulmonary Drugs Sales Volume (K Units) by Players (2012-2017)
Table Japan Pulmonary Drugs Sales Volume Market Share by Players (2012-2017)
Figure Japan Pulmonary Drugs Sales Volume Market Share by Players in 2016
Table Japan Pulmonary Drugs Sales Volume (K Units) by Type (2012-2017)
Table Japan Pulmonary Drugs Sales Volume Market Share by Type (2012-2017)
Figure Japan Pulmonary Drugs Sales Volume Market Share by Type in 2016
Table Japan Pulmonary Drugs Sales Volume (K Units) by Application (2012-2017)
Table Japan Pulmonary Drugs Sales Volume Market Share by Application (2012-2017)
Figure Japan Pulmonary Drugs Sales Volume Market Share by Application in 2016
Figure Southeast Asia Pulmonary Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure Southeast Asia Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Pulmonary Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table Southeast Asia Pulmonary Drugs Sales Volume (K Units) by Players (2012-2017)
Table Southeast Asia Pulmonary Drugs Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Pulmonary Drugs Sales Volume Market Share by Players in 2016
Table Southeast Asia Pulmonary Drugs Sales Volume (K Units) by Type (2012-2017)
Table Southeast Asia Pulmonary Drugs Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Pulmonary Drugs Sales Volume Market Share by Type in 2016
Table Southeast Asia Pulmonary Drugs Sales Volume (K Units) by Application (2012-2017)
Table Southeast Asia Pulmonary Drugs Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Pulmonary Drugs Sales Volume Market Share by Application in 2016
Figure India Pulmonary Drugs Sales (K Units) and Growth Rate (2012-2017)
Figure India Pulmonary Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Pulmonary Drugs Sales Price (USD/Unit) Trend (2012-2017)
Table India Pulmonary Drugs Sales Volume (K Units) by Players (2012-2017)
Table India Pulmonary Drugs Sales Volume Market Share by Players (2012-2017)
Figure India Pulmonary Drugs Sales Volume Market Share by Players in 2016
Table India Pulmonary Drugs Sales Volume (K Units) by Type (2012-2017)
Table India Pulmonary Drugs Sales Volume Market Share by Type (2012-2017)
Figure India Pulmonary Drugs Sales Volume Market Share by Type in 2016
Table India Pulmonary Drugs Sales Volume (K Units) by Application (2012-2017)
Table India Pulmonary Drugs Sales Volume Market Share by Application (2012-2017)
Figure India Pulmonary Drugs Sales Volume Market Share by Application in 2016
Table AstraZeneca plc Basic Information List
Table AstraZeneca plc Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca plc Pulmonary Drugs Sales Growth Rate (2012-2017)
Figure AstraZeneca plc Pulmonary Drugs Sales Global Market Share (2012-2017
Figure AstraZeneca plc Pulmonary Drugs Revenue Global Market Share (2012-2017)
Table Bayer AG? Basic Information List
Table Bayer AG? Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bayer AG? Pulmonary Drugs Sales Growth Rate (2012-2017)
Figure Bayer AG? Pulmonary Drugs Sales Global Market Share (2012-2017
Figure Bayer AG? Pulmonary Drugs Revenue Global Market Share (2012-2017)
Table Teva Pharmaceutical Industries Ltd.? Basic Information List
Table Teva Pharmaceutical Industries Ltd.? Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Industries Ltd.? Pulmonary Drugs Sales Growth Rate (2012-2017)
Figure Teva Pharmaceutical Industries Ltd.? Pulmonary Drugs Sales Global Market Share (2012-2017
Figure Teva Pharmaceutical Industries Ltd.? Pulmonary Drugs Revenue Global Market Share (2012-2017)
Table Actelion Pharmaceuticals, Inc. Basic Information List
Table Actelion Pharmaceuticals, Inc. Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Actelion Pharmaceuticals, Inc. Pulmonary Drugs Sales Growth Rate (2012-2017)
Figure Actelion Pharmaceuticals, Inc. Pulmonary Drugs Sales Global Market Share (2012-2017
Figure Actelion Pharmaceuticals, Inc. Pulmonary Drugs Revenue Global Market Share (2012-2017)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Pulmonary Drugs Sales Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Pulmonary Drugs Sales Global Market Share (2012-2017
Figure Boehringer Ingelheim GmbH Pulmonary Drugs Revenue Global Market Share (2012-2017)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Pulmonary Drugs Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche Ltd. Pulmonary Drugs Sales Global Market Share (2012-2017
Figure F. Hoffmann-La Roche Ltd. Pulmonary Drugs Revenue Global Market Share (2012-2017)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck & Co., Inc. Pulmonary Drugs Sales Growth Rate (2012-2017)
Figure Merck & Co., Inc. Pulmonary Drugs Sales Global Market Share (2012-2017
Figure Merck & Co., Inc. Pulmonary Drugs Revenue Global Market Share (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Pulmonary Drugs Sales Growth Rate (2012-2017)
Figure Novartis AG Pulmonary Drugs Sales Global Market Share (2012-2017
Figure Novartis AG Pulmonary Drugs Revenue Global Market Share (2012-2017)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline plc Pulmonary Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline plc Pulmonary Drugs Sales Global Market Share (2012-2017
Figure GlaxoSmithKline plc Pulmonary Drugs Revenue Global Market Share (2012-2017)
Table Sunovion Pharmaceuticals, Inc.? Basic Information List
Table Sunovion Pharmaceuticals, Inc.? Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sunovion Pharmaceuticals, Inc.? Pulmonary Drugs Sales Growth Rate (2012-2017)
Figure Sunovion Pharmaceuticals, Inc.? Pulmonary Drugs Sales Global Market Share (2012-2017
Figure Sunovion Pharmaceuticals, Inc.? Pulmonary Drugs Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pulmonary Drugs
Figure Manufacturing Process Analysis of Pulmonary Drugs
Figure Pulmonary Drugs Industrial Chain Analysis
Table Raw Materials Sources of Pulmonary Drugs Major Players in 2016
Table Major Buyers of Pulmonary Drugs
Table Distributors/Traders List
Figure Global Pulmonary Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Global Pulmonary Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Pulmonary Drugs Price (USD/Unit) and Trend Forecast (2017-2022)
Table Global Pulmonary Drugs Sales Volume (K Units) Forecast by Regions (2017-2022)
Figure Global Pulmonary Drugs Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Pulmonary Drugs Sales Volume Market Share Forecast by Regions in 2022
Table Global Pulmonary Drugs Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Pulmonary Drugs Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Pulmonary Drugs Revenue Market Share Forecast by Regions in 2022
Figure United States Pulmonary Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Pulmonary Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Pulmonary Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure China Pulmonary Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Pulmonary Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Europe Pulmonary Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Pulmonary Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Japan Pulmonary Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Pulmonary Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Pulmonary Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Pulmonary Drugs Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure India Pulmonary Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Pulmonary Drugs Sales (K Units) Forecast by Type (2017-2022)
Figure Global Pulmonary Drugs Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Pulmonary Drugs Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Pulmonary Drugs Revenue Market Share Forecast by Type (2017-2022)
Table Global Pulmonary Drugs Price (USD/Unit) Forecast by Type (2017-2022)
Table Global Pulmonary Drugs Sales (K Units) Forecast by Application (2017-2022)
Figure Global Pulmonary Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources